Statin Prescribing in the Elderly: Special Considerations
- 11 October 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Atherosclerosis Reports
- Vol. 19 (11), 47
- https://doi.org/10.1007/s11883-017-0683-9
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinThe New England Journal of Medicine, 2008
- Statins for Secondary Prevention in Elderly Patients: A Hierarchical Bayesian Meta-AnalysisJournal of the American College of Cardiology, 2008
- Identifying Patients for Aggressive Cholesterol Lowering: The Risk Curve ConceptThe American Journal of Cardiology, 2006
- Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary DiseaseThe New England Journal of Medicine, 2005
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Secondary Prevention of Coronary Heart Disease in the Elderly (With Emphasis on Patients ≥75 Years of Age)Circulation, 2002
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsThe New England Journal of Medicine, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsThe New England Journal of Medicine, 1996
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1994